Oncology partners

Caprion has distinguished itself by significant paid collaborations, compelling execution and scientific results in the discovery and development of functionally relevant novel therapeutic targets.

 

Biogen-Idec - Colon Cancer

This alliance is focused on the discovery and development of novel targets on the surface of colon epithelial tumor cells.

 

Abbott Laboratories – Non-small cell (NSC) Lung Cancer

This alliance is focused on the discovery and development of novel targets on the surface of NSC lung epithelial tumor cells.

 

ICOS – NSC Lung Cancer

This alliance is focused on the development of several novel NSC lung epithelial tumor targets that have emerged from previous Caprion research.